No abstract

CD34+ cell population of human omentum could be responsible for the clinical benefit of omental transplantation by promoting angiogenesis and synthesizing angiogenic growth factors to facilitate revascularization of injured tissue.

Over a span of 20 years, 137 patients with primary malignant tumors of the liver received treatment at the Memorial Cancer Center. Seventy‐one percent of the patients had hepatocellular carcinoma. Various modalities of therapy were applied in the treatment of these patients. Early diagnosis is mandatory to increase the resectability rate. Thirty‐two patients had some form of hepatic resection of whom 5 survived more than 5 years. Good palliation and prolongation of life occurred in 2 out of 6 patients who had hepatic artery infusion by chemotherapeutic agents. The role of hepatic transplantation and re‐vascularization of segments of the liver in extending the scope of hepatic resection remains in the experimental phase.

No abstract

No abstract